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The aim of this paper is to address adenocarcinoma of the duodenum by reporting a case, reviewing 
the literature and discussing current knowledge, diagnostic modalities and treatment options. We 
present a case of a 42-year-old patient with duodenal adenocarcinoma at the second portion invading 
surrounding organs. The patient had a previous history of colon malignancy and was diagnosed with 
a new tumour formation on regular CT (computed tomography) follow-up. Pylorus-preserving 
pancreaticoduodenectomy (PPPD) was preformed for this T4 N2 M1 tumor. 
Duodenal adenocarcinoma is a rare tumor, most frequently involving the second duodenal portion. It 
has no specific symptoms and it is difficult to diagnose it due to its rarity and clinical presentation. 
Diagnosis, exact localization, and involvement of lymph nodes and surrounding organs have an 
impact on surgical strategy and prognosis.  
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Although the small intestine represents 
90% of the gastrointestinal mucosal surface, 
malignancies of the small intestine account for 
only 1% [1, 2]. Duodenal involvement is 30–
45% with the most frequent location at the 
second portion ( 42.8–81.8%) [3]. 
Clinical presentation of duodenal carci-
noma is unrevealing. Abdominal cramps, nau-
sea and postprandial pain are nonspecific and 
lead to misdiagnosis and delay in diagnosis. 
Intestinal obstruction, anaemia, weight loss, jaun-
dice, secondary to biliary obstruction and pal-
pable abdominal mass are related to advanced 
disease. [1, 4–6 ] 
We report a case of advanced duodenal 
adenocarcinoma and discuss diagnosis, treat-
ment and prognostic factors by reviewing the 
literature. 
Case presentation 
A 42-year-old patient presenting with 
tumour formation in the second portion of the 
duodenum involving the right kidney. The tu-
mour formation was diagnosed after a regular 
yearly follow-up when CT of the abdomen was 
performed. The patient was admitted as an acute 
abdomen case 3.5 years ago in emergency set-
ting and was operated on. Obstructive carci-
noma of the caecum with consecutive perfor a-
ted appendicitis was found. A right haemico-
lectomy with ileo-transverso anastomosis was 
performed. The pathologist report was: Adeno-
carinoma of the caecum, acute gangrenous per-
forated appendicitis with diffuse fibrino-puru-
lent peritonitis. The pathological stage of the 
tumor was pT3 pN1 pMx, of 15 lymph nodes, 
2 had metastatic deposits. Regular follow-up 
was performed, on the second early colono-
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scopy two polyps were diagnosed on the rema-
inning colon (one on the sigmoid and one on 
the rectum). On the CT scan tumour formation 
invading the duodenum, right kidney and liver 
was suspected (Plates 1, 2 and 3). Upper 
gastrointestinal endoscopy was performed and 
involvement of the duodenum was confirmed. 
CEA and CA 19–9 antigens were in the normal 
range on follow-up. The patient reported that 
he had had some back pain in the last two 
months and noticed a black stool from time to 
time; he lost 5–7 kg in that time. Explorative 
laparotomy was performed and the tumour for-
mation was evaluated, no distant metastasis 
and no peritoneal involvement was confirmed. 
Tumor formation extended from the second 
portion of the duodenum to the flexure between 
the second and third portions. The fundus of 
the gall bladder, a portion of the 5th segment of 
the liver and right kidney were also involved in 
the tumour. Considering the patient’s age and 
condition, extensive surgical treatment was 
performed. "En block" resection of the 5th liver 
segment, cholecystectomy, right nephrectomy 
and pylorus-preserving pancreaticoduodenecto-
my. The postoperative period was prolonged, a 
small pancreatic leakage was evident on the 5th 
postoperative day but was treated conservati-
vely. Leakage was localized and drained on a 
drainage tube placed intra operative ly and cea-
sed on the 14th day. Oral feeding was resumed 
on the 10th day and the patient was discharged on 
the 15th postoperative day. The histopathological 
findings reported: Adenocarcinoma of the duode-
num with invasion of the gall bladder, liver and 
right kidney. A negative margin of resection was 
confirmed, of 13 lymph nodes 4 had metastatic 
deposits. The pathological stage was pT4 pN2 
pM1 (invasion in the kidney was considered as 
metastasis). Since the patient had been operated 
previously for adenocarcinoma of the colon the 
first impression was that it was a recurrence. 
Hystopathological immunohystochemical ana-
lysis implied that the primary origin of this 
adenocarcinoma was the duodenum (strong 
membrane stain for CKWS, cythoplasmic gra-
nules positive for chromogranin, some cells 
showing cytoplasmic positivity for NSE and 
discrete positive signal of tumour cell on TTF 
(Picture 4). Adjuvant chemotherapy was advi-
sed by the oncologist. 
 
Picture 1 – Infiltration of the gold bladder and hepatic tissue 
 
Picture 2 – Position  the tumor arising from duodenum  between the  kidney and liver 
 
CKWS – cytokeratin wide spectrum; NSE – neuron specific enolase; TTF – thyroid transcription factor  
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Picture 3 – Involvement of the right kidney 
 
 
Picture 4 – TTF -thyroid transcription factor positive tumor cells 
 
Discussion 
Primary adenocarcinoma of the duode-
num is rare [1, 2]. Involvement of the second 
portion is the most common [3] and the case 
we present can be included in this group.  
In our case symptoms were obscured by 
the fact that the patient had had previous colon 
malignancy. Black stool, back pain and weight 
loss could point towards upper gastrointestinal 
process [8] and lead to endoscopy, but attention 
was directed towards a regular follow-up and 
previous malignancy. Colorectal cancer increa-
ses the risk of developing small bowel cancer, 
other conditions such as FAP (familial adeno-
matous polyposis), HNPCC (hereditary non-
polyposis colon cancer), Peutz -Jeger and Crohn 
disease also increase the risk [4, 5, 7].  
Endoscopy was performed and the biopsy 
was negative. Upper gastrointestinal endoscopy 
is the diagnostic procedure for duodenal tumo-
urs over 25% [3, 9, 10]. The advantage is visu-
alization  of  the process  and the opportunity to  
 
perform a biopsy. In our case endoscopy was 
performed after the CT of the abdomen when a 
mass in the upper right abdomen involving the 
duodenum was found. 
CT is required for confirming, staging 
and treatment planning. Using CT enteroclysis 
(CTE), contrast and water enhanced multide-
tector CTE sensitivity for lesions up to 2cm is 
over 80% and specificity over 90% [9, 11]. The 
mass on CT was presumed to be a recurrence 
of the colon cancer and involvement of the sur-
rounding organs was evident. Intravenous and 
oral contrast-enhanced CT was used. 
Radical resection is the only potential 
curative procedure. DCP (duodenocephalic pan-
createctomy) is the method of choice for lesi-
ons in the first and second portion of the duo-
denum [6, 12]. We used the modified pylorus-
preserving pancreaticoduodenectomy (PPPD). 
The perioperative mortality rate for radical re-
section is 1% and morbidity is around 50% [13, 
14]. Pancreatic leakage is a common compli-
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cation and consists of 16% of the curative re-
sections group; our patient had this complica-
tion and was treated conservatively. 
The survival rates for duodenal adenocar-
cinoma at 5 years are from 6–18% [12, 15]; in 
patients with curative resections they are 50% 
at 5 years [3, 13]. The prognostic factors of age, 
weight loss, nodal metastasis, positive resecti-
on margin and advanced tumour stage are asso-
ciated with short survival [13]. Invasion of the 
pancreas is an important prognostic factor, T4 
tumor stage patients have a shorter survival 
(median survival 11 months) compared with 
T1-T3 (median survival 29 months) [10, 16] 
Postoperative morbidity is an additional prog-
nostic factor, abdominal complications have a 
significant impact on median survival (180 
months with an uneventful postoperative course 
and 52 months after abdominal complication) 
[17]. An additional prognostic factor can be 
cancer-directed therapy (surgery), patients who 
have had cancer-directed surgery (radical-cura-
tive surgery) have better overall survival [10, 15]. 
In conclusion, duodenal adenocarcinoma 
is a rare tumour that, due to its rarity and 
unrevealing symptoms, is diagnosed in its 
advanced stages. This accounts for the low rate 
of tumors amenable for resection. The case that 
we present was diagnosed in the advanced 
tumour stage mainly because the symptoms 
were obscured by the previous malignancy. 
Diagnosis, preoperative staging and treatment-
planning are crucial and cancer-directed 
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Цел на оваа публикација е да се обработи 
аденокарциномот на дуоденумot преку презен-
тација на случај и преглед на литератураta, да 
се согледаат ставовите, дијагностичките можно-
сти и начинот на третман. Презентираме случај 
на 42-годишен пациент со аденокарцином кој го 
зафаќа вториот дуоденален сегмент и ги инфил-
трира околните органи. Пациентот има историја 
на претходен карцином на колон и е дијагно-
стициран со туморската формација на дуодену-
мот на редовна контрола со компјутерiзирана 
томографија. Направена е пилорус презерви-
рачка панкреатикодуоденектомија за оваа T4 N2 
M1 туморската формација.  
Дуоденалниот аденокарцином е редок ту-
мор и најчесто го зафаќа вториот дуоденален 
сегмент. Нема специфична клиничка презента-
ција и затоа многу тешко се дијагностицира. 
Дијагнозата, прецизната локализација, зафаќа-
њето на околните органи и ширењето во лимф-
ните јазли има влијание на хируршката страте-
гија и прогноза. 
 
Клучни зборови: дуоденум, дуоденален аденокар-
цином, втор сегмент на дуоденум, хирургија, пилорус 
презервирачка панкреатикодуоденектомија, ПППД. 
 
 
